{"transactions":[{"id":2139694,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-10-11T20:34:36.000Z","date":"2022-10-09","kind":"tax_withholding","acquired":false,"shares":2948,"price":19.62,"value":57839.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 7, 2022."}],"balance_after":172561,"source":{"system":"sec-edgar","filing":"0001628280-22-026251","document":"wf-form4_166552045769875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022026251/wf-form4_166552045769875.xml","form_type":"4"}},{"id":2139693,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-10-11T20:34:36.000Z","date":"2022-10-09","kind":"tax_withholding","acquired":false,"shares":1978,"price":19.62,"value":38808.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 7, 2022."}],"balance_after":175509,"source":{"system":"sec-edgar","filing":"0001628280-22-026251","document":"wf-form4_166552045769875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022026251/wf-form4_166552045769875.xml","form_type":"4"}},{"id":2150761,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-09-27T20:30:52.000Z","date":"2022-09-26","kind":"tax_withholding","acquired":false,"shares":2216,"price":18.41,"value":40796.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2022."}],"balance_after":177487,"source":{"system":"sec-edgar","filing":"0001628280-22-025562","document":"wf-form4_166431062499276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022025562/wf-form4_166431062499276.xml","form_type":"4"}},{"id":2150760,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-09-27T20:30:52.000Z","date":"2022-09-25","kind":"tax_withholding","acquired":false,"shares":1662,"price":18.69,"value":31062.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 23, 2022."}],"balance_after":179703,"source":{"system":"sec-edgar","filing":"0001628280-22-025562","document":"wf-form4_166431062499276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022025562/wf-form4_166431062499276.xml","form_type":"4"}},{"id":2173327,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-08-26T20:21:58.000Z","date":"2022-08-25","kind":"tax_withholding","acquired":false,"shares":1146,"price":24.89,"value":28523.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2022."}],"balance_after":181365,"source":{"system":"sec-edgar","filing":"0001628280-22-023765","document":"wf-form4_166154530195212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022023765/wf-form4_166154530195212.xml","form_type":"4"}},{"id":2236773,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-06-10T20:40:41.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":1036,"price":14.841,"value":15375.276,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Myriad Genetics, Inc. 2012 Amended and Restated Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":182511,"source":{"system":"sec-edgar","filing":"0001519749-22-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974922000010/edgardoc.xml","form_type":"4"}},{"id":2318209,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-25T21:04:51.000Z","date":"2022-03-24","kind":"tax_withholding","acquired":false,"shares":2164,"price":25.32,"value":54792.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022."}],"balance_after":181475,"source":{"system":"sec-edgar","filing":"0001519749-22-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974922000008/edgardoc.xml","form_type":"4"}},{"id":2318208,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-25T21:04:51.000Z","date":"2022-03-24","kind":"tax_withholding","acquired":false,"shares":1477,"price":25.32,"value":37397.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022."}],"balance_after":183639,"source":{"system":"sec-edgar","filing":"0001519749-22-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974922000008/edgardoc.xml","form_type":"4"}},{"id":2320469,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-23T20:57:15.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":19238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":185116,"source":{"system":"sec-edgar","filing":"0001519749-22-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974922000006/edgardoc.xml","form_type":"4"}},{"id":2366897,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-01T21:55:02.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":23.98,"expiration_date":"2022-03-07","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001519749-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974922000004/edgardoc.xml","form_type":"4"}},{"id":2366896,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2022-03-01T21:55:02.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":23.98,"expiration_date":"2022-03-07","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001519749-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974922000004/edgardoc.xml","form_type":"4"}},{"id":2366895,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-01T21:55:02.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":3500,"price":25,"value":87500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":165878,"source":{"system":"sec-edgar","filing":"0001519749-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974922000004/edgardoc.xml","form_type":"4"}},{"id":2366894,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-01T21:55:02.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":3500,"price":23.98,"value":83930.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock received upon exercise of a stock option award."}],"balance_after":169378,"source":{"system":"sec-edgar","filing":"0001519749-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974922000004/edgardoc.xml","form_type":"4"}},{"id":2366893,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-01T21:55:02.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":7000,"price":25,"value":175000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":165878,"source":{"system":"sec-edgar","filing":"0001519749-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974922000004/edgardoc.xml","form_type":"4"}},{"id":2366892,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-03-01T21:55:02.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":7000,"price":23.98,"value":167860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock received upon exercise of a stock option award."}],"balance_after":172878,"source":{"system":"sec-edgar","filing":"0001519749-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974922000004/edgardoc.xml","form_type":"4"}},{"id":2386451,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2022-02-18T22:16:48.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":19520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics.  On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics.  Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025."}],"balance_after":165878,"source":{"system":"sec-edgar","filing":"0001519749-22-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974922000002/edgardoc.xml","form_type":"4"}},{"id":2491196,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-12-01T23:19:37.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":143,"price":21.981,"value":3143.283,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Myriad Genetics, Inc. 2012 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":146358,"source":{"system":"sec-edgar","filing":"0001519749-21-000019","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000019/edgardoc.xml","form_type":"4"}},{"id":2544929,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-10-12T20:42:56.000Z","date":"2021-10-09","kind":"tax_withholding","acquired":false,"shares":2948,"price":30.88,"value":91034.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021."}],"balance_after":146215,"source":{"system":"sec-edgar","filing":"0001519749-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000017/edgardoc.xml","form_type":"4"}},{"id":2544928,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-10-12T20:42:56.000Z","date":"2021-10-09","kind":"tax_withholding","acquired":false,"shares":1978,"price":30.88,"value":61080.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 41,021 shares of Myriad common stock that were omitted from the reporting person's Form 3, which was amended to reflect such shares on October 12, 2021."}],"balance_after":149163,"source":{"system":"sec-edgar","filing":"0001519749-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000017/edgardoc.xml","form_type":"4"}},{"id":2559321,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:48:23.000Z","date":"2021-09-26","kind":"tax_withholding","acquired":false,"shares":2216,"price":33.31,"value":73814.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021."}],"balance_after":110120,"source":{"system":"sec-edgar","filing":"0001519749-21-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000015/edgardoc.xml","form_type":"4"}},{"id":2559320,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-27T23:48:23.000Z","date":"2021-09-25","kind":"tax_withholding","acquired":false,"shares":3878,"price":33.31,"value":129176.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021."}],"balance_after":112336,"source":{"system":"sec-edgar","filing":"0001519749-21-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000015/edgardoc.xml","form_type":"4"}},{"id":2561264,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-23T21:26:41.000Z","date":"2021-09-21","kind":"grant","acquired":true,"shares":26598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on October 8, 2020, subject to accomplishment of pre-determined performance metrics.  On September 21, 2021, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics.  Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024."}],"balance_after":116214,"source":{"system":"sec-edgar","filing":"0001519749-21-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000013/edgardoc.xml","form_type":"4"}},{"id":2563468,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-21T22:18:42.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":73225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":73225},"source":{"system":"sec-edgar","filing":"0001519749-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000011/edgardoc.xml","form_type":"4"}},{"id":2563467,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-09-21T22:18:42.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":3775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":26.49,"expiration_date":"2021-09-17","underlying":"Common Stock","underlying_shares":3775},"source":{"system":"sec-edgar","filing":"0001519749-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000011/edgardoc.xml","form_type":"4"}},{"id":2563466,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-21T22:18:42.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":2966,"price":33.72,"value":100013.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the net exercise of outstanding stock options. The reporting person received 809 shares of common stock on net exercise of options to purchase 3,775 shares of common stock. The company withheld 2,966 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72."}],"balance_after":89616,"source":{"system":"sec-edgar","filing":"0001519749-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000011/edgardoc.xml","form_type":"4"}},{"id":2563465,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-21T22:18:42.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":3775,"price":26.49,"value":99999.75,"ownership":{"direct":true},"balance_after":92582,"source":{"system":"sec-edgar","filing":"0001519749-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000011/edgardoc.xml","form_type":"4"}},{"id":2563464,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-21T22:18:42.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":64480,"price":33.72,"value":2174265.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the net exercise of outstanding stock options. The reporting person received 8,745 shares of common stock on net exercise of options to purchase 73,225 shares of common stock. The company withheld 64,480 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72."}],"balance_after":88807,"source":{"system":"sec-edgar","filing":"0001519749-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000011/edgardoc.xml","form_type":"4"}},{"id":2563463,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-09-21T22:18:42.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":73225,"price":26.49,"value":1939730.25,"ownership":{"direct":true},"balance_after":153287,"source":{"system":"sec-edgar","filing":"0001519749-21-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000011/edgardoc.xml","form_type":"4"}},{"id":2590056,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-08-27T01:58:09.000Z","date":"2021-08-25","kind":"tax_withholding","acquired":false,"shares":1148,"price":34.81,"value":39961.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2021."}],"balance_after":80062,"source":{"system":"sec-edgar","filing":"0001519749-21-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000007/edgardoc.xml","form_type":"4"}},{"id":2684621,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-06-03T22:45:34.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":1082,"price":15.861,"value":17161.602,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Myriad Genetics, Inc. 2012 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":81210,"source":{"system":"sec-edgar","filing":"0001519749-21-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000006/edgardoc.xml","form_type":"4"}},{"id":2768713,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-30T22:31:03.000Z","date":"2021-03-29","kind":"exercise","acquired":false,"shares":21966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":24.89,"expiration_date":"2021-05-25","underlying":"Common Stock","underlying_shares":21966},"source":{"system":"sec-edgar","filing":"0001519749-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000004/edgardoc.xml","form_type":"4"}},{"id":2768712,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-30T22:31:03.000Z","date":"2021-03-29","kind":"exercise","acquired":false,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":19.47,"expiration_date":"2021-09-13","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001519749-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000004/edgardoc.xml","form_type":"4"}},{"id":2768711,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-03-30T22:31:03.000Z","date":"2021-03-29","kind":"exercise","acquired":false,"shares":8034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":24.89,"expiration_date":"2021-05-25","underlying":"Common Stock","underlying_shares":8034},"source":{"system":"sec-edgar","filing":"0001519749-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000004/edgardoc.xml","form_type":"4"}},{"id":2768710,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-03-30T22:31:03.000Z","date":"2021-03-29","kind":"sale","acquired":false,"shares":8034,"price":30,"value":241020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":80128,"source":{"system":"sec-edgar","filing":"0001519749-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000004/edgardoc.xml","form_type":"4"}},{"id":2768709,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-03-30T22:31:03.000Z","date":"2021-03-29","kind":"exercise","acquired":true,"shares":8034,"price":24.89,"value":199966.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock received upon exercise of a stock option award."}],"balance_after":88162,"source":{"system":"sec-edgar","filing":"0001519749-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000004/edgardoc.xml","form_type":"4"}},{"id":2768708,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-03-30T22:31:03.000Z","date":"2021-03-29","kind":"sale","acquired":false,"shares":21966,"price":30,"value":658980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":80128,"source":{"system":"sec-edgar","filing":"0001519749-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000004/edgardoc.xml","form_type":"4"}},{"id":2768707,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-03-30T22:31:03.000Z","date":"2021-03-29","kind":"exercise","acquired":true,"shares":21966,"price":24.89,"value":546733.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock received upon exercise of a stock option award."}],"balance_after":102094,"source":{"system":"sec-edgar","filing":"0001519749-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000004/edgardoc.xml","form_type":"4"}},{"id":2768706,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-03-30T22:31:03.000Z","date":"2021-03-29","kind":"sale","acquired":false,"shares":28000,"price":30,"value":840000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":80128,"source":{"system":"sec-edgar","filing":"0001519749-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000004/edgardoc.xml","form_type":"4"}},{"id":2768705,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-03-30T22:31:03.000Z","date":"2021-03-29","kind":"exercise","acquired":true,"shares":28000,"price":19.47,"value":545160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock received upon exercise of a stock option award."}],"balance_after":108128,"source":{"system":"sec-edgar","filing":"0001519749-21-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000004/edgardoc.xml","form_type":"4"}},{"id":2771111,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2021-03-26T20:45:40.000Z","date":"2021-03-24","kind":"grant","acquired":true,"shares":13326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":80128,"source":{"system":"sec-edgar","filing":"0001519749-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974921000002/edgardoc.xml","form_type":"4"}},{"id":3008752,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Human Resources"}}],"security":"Common Stock","published_at":"2020-10-13T12:21:28.000Z","date":"2020-10-08","kind":"grant","acquired":true,"shares":17853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024."}],"balance_after":66802,"source":{"system":"sec-edgar","filing":"0001519749-20-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974920000011/edgardoc.xml","form_type":"4"}},{"id":3019138,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Human Resources"}}],"security":"Common Stock","published_at":"2020-10-01T21:43:00.000Z","date":"2020-09-30","kind":"disposition_to_issuer","acquired":false,"shares":2218,"price":13.04,"value":28922.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":48949,"source":{"system":"sec-edgar","filing":"0001519749-20-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974920000009/edgardoc.xml","form_type":"4"}},{"id":3021929,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Human Resources"}}],"security":"Common Stock","published_at":"2020-09-28T17:15:35.000Z","date":"2020-09-26","kind":"disposition_to_issuer","acquired":false,"shares":2218,"price":12.44,"value":27591.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":51167,"source":{"system":"sec-edgar","filing":"0001519749-20-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974920000007/edgardoc.xml","form_type":"4"}},{"id":3021928,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Human Resources"}}],"security":"Common Stock","published_at":"2020-09-28T17:15:35.000Z","date":"2020-09-25","kind":"disposition_to_issuer","acquired":false,"shares":1664,"price":12.44,"value":20700.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":53385,"source":{"system":"sec-edgar","filing":"0001519749-20-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974920000007/edgardoc.xml","form_type":"4"}},{"id":3021927,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":116191,"kind":"person","name":"Hart Jayne B.","position":1,"cik":"0001519749","reported_name":"Hart Jayne B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Human Resources"}}],"security":"Common Stock","published_at":"2020-09-28T17:15:35.000Z","date":"2020-09-25","kind":"disposition_to_issuer","acquired":false,"shares":2218,"price":12.44,"value":27591.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":55049,"source":{"system":"sec-edgar","filing":"0001519749-20-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151974920000007/edgardoc.xml","form_type":"4"}}]}